These actions seem to explain, at least in part, the in vitro anti-angiogenic effects of IFN/5-FU, suggesting that they could also contribute to the synergistic anti-tumor effects of these compounds on HCC through remodeling of tumor vasculature and modulating drug delivery. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.